Cite
Study of the Spanish Society of Medical Oncology (SEOM) on the access to oncology drugs and predictive biomarkers in Spain
MLA
Rodríguez-Lescure, A., et al. “Study of the Spanish Society of Medical Oncology (SEOM) on the Access to Oncology Drugs and Predictive Biomarkers in Spain.” Clinicaltranslational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, vol. 22, no. 12, Apr. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b1cc97a12daf2cd6858023b88ee4fb23&authtype=sso&custid=ns315887.
APA
Rodríguez-Lescure, A., de la Peña, F. A., Aranda, E., Calvo, A., Felip, E., Garrido, P., Vera, R., & Universitat Autònoma de Barcelona. (2020). Study of the Spanish Society of Medical Oncology (SEOM) on the access to oncology drugs and predictive biomarkers in Spain. Clinicaltranslational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 22(12).
Chicago
Rodríguez-Lescure, A., F. A. de la Peña, E. Aranda, A. Calvo, Enriqueta Felip, Pilar Garrido, Ruth Vera, and Universitat Autònoma de Barcelona. 2020. “Study of the Spanish Society of Medical Oncology (SEOM) on the Access to Oncology Drugs and Predictive Biomarkers in Spain.” Clinicaltranslational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 22 (12). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b1cc97a12daf2cd6858023b88ee4fb23&authtype=sso&custid=ns315887.